TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling-Reference-Cited by-同舟云学术

TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

Published:2004-10 Issue:4 Volume:21 Page:491-501
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Becker Christoph,Fantini Massimo C.,Schramm Christoph,Lehr Hans A.,Wirtz Stefan,Nikolaev Alexei,Burg Jürgen,Strand Susanne,Kiesslich Ralf,Huber Samuel,Ito Hiroaki,Nishimoto Norihiro,Yoshizaki Kazuyuki,Kishimoto Tadamitsu,Galle Peter R.,Blessing Manfred,Rose-John Stefan,Neurath Markus F.

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference32 articles.

1. Roles of STAT3 defined by tissue-specific gene targeting;Akira;Oncogene,2000

2. Blockade of IL-6 trans-signaling suppresses T cell resistance against apoptosis in chronic intestinal inflammation;Atreya;Nat. Med,2000

3. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells;Becker;J. Clin. Invest,2003

4. TACE is required for the activation of the EGFR by TGF-alpha in tumors;Borrell-Pages;EMBO J,2003

5. Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress;Chen;Immunity,2004

Cited by 655 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ALK5/VEGFR2 dual inhibitor TU2218 alone or in combination with immune checkpoint inhibitors enhances immune-mediated antitumor effects;Cancer Immunology, Immunotherapy;2024-08-06

2. Recent advances and molecular mechanisms of TGF-β signaling in colorectal cancer, with focus on bioactive compounds targeting;Biomedicine & Pharmacotherapy;2024-08

3. NF-κB role on tumor proliferation, migration, invasion and immune escape;Cancer Gene Therapy;2024-07-20

4. Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects;Metabolism;2024-06

5. Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities;Signal Transduction and Targeted Therapy;2024-05-22